MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting β-catenin-mediated EMT signaling and is associated with poor prognosis.
- DOI
- 10.1186/s10020-026-01540-2
- Published
- 2026 Jul 6
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-026-01540-2,
title = {MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting β-catenin-mediated EMT signaling and is associated with poor prognosis.},
author = {Mo JS and Noh SJ and Kim KM and Bae JS},
year = {2026},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-026-01540-2},
url = {https://doi.org/10.1186/s10020-026-01540-2}
}RIS
TY - JOUR TI - MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting β-catenin-mediated EMT signaling and is associated with poor prognosis. AU - Mo JS AU - Noh SJ AU - Kim KM AU - Bae JS PY - 2026 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-026-01540-2 UR - https://doi.org/10.1186/s10020-026-01540-2 ER -
APA
JS, M., SJ, N., KM, K., & JS, B. (2026). MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting β-catenin-mediated EMT signaling and is associated with poor prognosis.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01540-2
Source records
- pubmed · retrieved 2026-09-26T05:23:03.068Z